
Q & A: Dr. Haifeng Yang and Dr. William Kim
Oct . 26 . 2020
Research
Dr. Haifeng Yang and Dr. William Kim received a 2020 Advanced Discovery Award for their project to “Investigating the anti-tumor efficacy of a STING agonist on PBRM1-deficient ccRCC tumors,” which will examine whether a novel compound can help in kidney cancer treatment. Both Yang and Kim trained with Dr. William Kaelin, Jr. at the Dana Farber Cancer Institute as postdoctoral…
Read More